Day 7: In view of the sedative effect, studies are ongoing to assess the abuse potential for #daridorexant. At clinical doses, the risk appears low for abuse or dependence. Unknown at higher doses, or for those with history of addiction. Schedule IV Controlled Drug in USA
Day 5: Common adverse drug effects for #daridorexant include headache, sleepiness, dizziness, GI disorders. Hypersensitivity, hallucinations & abnormal dreams are all uncommon (NOT exhaustive)
Day 4: #daridorexant selectively antagonises orexin 1 & 2 receptors. Neuropeptides orexin A/B normally act on these receptors to increase wakefulness; preventing docking promotes sleep onset & maintenance
Day 3: #daridorexant has ↑absorption, bioavailability, Vd, protein binding. Extensive hepatic metabolism by CYP3A4/no active metabolites. Minor inhibition OAT & P-gp transporters. Main excr faeces, 28% renal. Terminal t½ 8hrs. Dose adjust moderate+ hepatic impairment. No renal function adjustments.
Day 2: #daridorexant tablet is licensed for insomnia in adults if symptoms present for > 3mnths & other interventions have been ineffective. 25 or 50mg oral tablet once daily taken 30 minutes before bedtime. Duration of treatment ‘as short as possible’ with efficacy data up to 1 year
Day 1: In the late 1990s, investigations into brain feeding systems led to discovery of orexin peptides/receptors, a system stimulating arousal, hunger & food seeking behaviour. As a drug target, blockade was found to promote sleepiness. #daridorexant licensed c. 2022
New series '7 days of #daridorexant' starting today - hope you enjoy
Kein #Rebound unter Schlafmittel #Daridorexant (QUVIVIQ)?
Laut Anbieter tritt nach Absetzen des Schlafmittels keine Rebound-Insomnie auf. Aber gilt das für alle Patienten?
www.arznei-telegramm.de/html/2025_11...
Die November-Ausgabe ist erschienen – Themen: #Clopidogrel statt ASS zur Sekundärprophylaxe bei #KHK? Nicht immer! – #Varizella-zoster-Totimpfstoff #SHINGRIX bei Zoster in der Anamnese? – Kein #Rebound unter Schlafmittel #Daridorexant (QUVIVIQ)? u.a.
www.arznei-telegramm.de/archive/arcc...
Finally, #daridorexant and #melatonin 2 mg PR do not require special switching or #deprescribing protocols. Several #sedative-hypnotic dosage reduction algorithms are proposed in this work for #clinical use in real world settings.
Multi-component #CBT-I, #daridorexant, #eszopiclone, and #melatonin 2 mg PR were shown to facilitate the gradual discontinuation of hypnotic #benzodiazepines/Z-drugs within a cross-tapered program, which can be delayed when necessary.
This multicenter, randomized, double-blind, parallel-group, placebo-controlled Phase III clinical trial evaluated the efficacy and safety of #daridorexant in Chinese patients with insomnia disorder. academic.oup.com/sleep/articl...
www.linkedin.com/pulse/nxera-...
Nxera and Shionogi Deliver Innovation with QUVIVIQ™ Launch, Targeting Japan's Insomnia Epidemic
kstrategyand.com/pharma-news
#NxeraPharma #Shionogi #QUVIVIQ #Daridorexant #InsomniaTreatment #SleepHealth #MentalHealthSupport #Humanteconomy #Humantec
Nxera Pharma kicks off Phase 3 trial for daridorexant, a promising treatment for insomnia. Could this be the solution for millions struggling with sleep? #Daridorexant #SleepDisorder #BetterSleep #HealthNews #BetterSleep #HealthNews #SleepDisorder #Insomnia #PharmaInnovation #SleepWell #HealthCare
Sleeping tablets & ME/CFS: Daridorexant - any experience?
ME brought bad sleep and I've been using Promethazine (four/five nights on and Valerian for three off nights) successfully, but I feel hella groggy in the AM. (+LDN has meant VERY vivid dreams).
#pwME #MECFS #sleep #Daridorexant
